Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/26414
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDimeo, Paulen_UK
dc.contributor.authorMoller, Verneren_UK
dc.date.accessioned2017-12-21T04:36:16Z-
dc.date.available2017-12-21T04:36:16Z-
dc.date.issued2017-12-18en_UK
dc.identifier.urihttp://hdl.handle.net/1893/26414-
dc.description.abstractFirst paragraph: Four-time Tour de France winnerChris Froome’spositive test for high levels of the asthma drugsalbutamolin September during the Vuelta a Espana race has prompted much debate on the rules surrounding medicines in sport. In essence, some drugs are not allowed, and others are allowed up to a threshold level under aTherapeutic Use Exemption(TUE). This creates problems in establishing the threshold level and around accidental over-use, but also opens the door to unethical behaviour.en_UK
dc.language.isoenen_UK
dc.publisherThe Conversation Trusten_UK
dc.relationDimeo P & Moller V (2017) Elite sport: time to scrap the therapeutic exemption system of banned medicines. The Conversation. 18.12.2017. https://theconversation.com/elite-sport-time-to-scrap-the-therapeutic-exemption-system-of-banned-medicines-89252en_UK
dc.rightsThe Conversation uses a Creative Commons Attribution NoDerivatives licence. You can republish their articles for free, online or in print. Licence information is available at: http://creativecommons.org/licenses/by-nd/4.0/en_UK
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/en_UK
dc.titleElite sport: time to scrap the therapeutic exemption system of banned medicinesen_UK
dc.typeNewspaper/Magazine Articleen_UK
dc.citation.issnNo ISSNen_UK
dc.citation.publicationstatusPublisheden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.identifier.urlhttps://theconversation.com/elite-sport-time-to-scrap-the-therapeutic-exemption-system-of-banned-medicines-89252en_UK
dc.publisher.addressLondonen_UK
dc.contributor.affiliationSporten_UK
dc.contributor.affiliationAarhus Universityen_UK
dc.identifier.wtid1020864en_UK
dc.contributor.orcid0000-0002-4219-7687en_UK
dcterms.dateAccepted2017-12-18en_UK
dc.date.filedepositdate2017-12-20en_UK
rioxxterms.typeOtheren_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorDimeo, Paul|0000-0002-4219-7687en_UK
local.rioxx.authorMoller, Verner|en_UK
local.rioxx.projectInternal Project|University of Stirling|https://isni.org/isni/0000000122484331en_UK
local.rioxx.freetoreaddate2017-12-20en_UK
local.rioxx.licencehttp://creativecommons.org/licenses/by-nd/4.0/|2017-12-20|en_UK
local.rioxx.filenameDimeo-Conversation-2017.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.sourceNo ISSNen_UK
Appears in Collections:Faculty of Health Sciences and Sport Newspaper/Magazine Articles

Files in This Item:
File Description SizeFormat 
Dimeo-Conversation-2017.pdfFulltext - Published Version2.32 MBAdobe PDFView/Open


This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.